Sarah Michelle Skidmore

Title: Innovations by Sarah Michelle Skidmore in Biodegradable Polymer Formulations

Introduction

Sarah Michelle Skidmore is an accomplished inventor based in Lafayette, IN, recognized for her innovative contributions in the field of biodegradable polymer formulations. With a total of three patents to her name, Skidmore's work primarily focuses on enhancing the efficacy of protein drugs, particularly botulinum toxin, through advanced delivery methods.

Latest Patents

Skidmore's latest patents detail methodologies for developing biodegradable microparticles designed for the delivery of protein drugs. These innovative formulations involve a multi-step process that includes the precipitation and washing of proteins with organic solvents to eliminate water. This method is crucial in maintaining the bioactivity of the protein drugs by preventing exposure to potentially damaging water/solvent interfaces. The resulting biodegradable microparticles, formed from one or more biodegradable polymers, effectively encapsulate protein agents such as botulinum toxin. Furthermore, these formulations can also be engineered into thermogels or crosslinked hydrogels. The focus on stability and controlled release has significant implications for the sustained efficacy of therapeutic agents.

Career Highlights

Throughout her career, Sarah Michelle Skidmore has been affiliated with prominent companies such as Akina, Inc. and Sk Joint Ventures II, LLC. Her research and technological advancements have contributed greatly to both these organizations, allowing for innovation in drug delivery systems.

Collaborations

Skidmore has collaborated with esteemed professionals in her field, including Kinam Park and Yeonhee Yun. Through these partnerships, her work has gained further depth and insight, facilitating breakthroughs in the application of biodegradable polymers for drug delivery.

Conclusion

With a focused approach to innovation in biodegradable polymer formulations, Sarah Michelle Skidmore has made significant strides in enhancing the delivery and efficacy of essential protein drugs such as botulinum toxin. As she continues to explore new avenues for research and development, her contributions hold promise for advancing the pharmaceutical field.